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The African mosquito Anopheles gambiae is the insect vector responsible for half of 
worldwide malaria infections.  One option for reducing malaria is genetic 
manipulation of the vector.  By creating transgenic mosquitoes incapable of spreading 
the malaria pathogen, the human-mosquito-human cycle of infection may be 
interrupted.  In order for the engineered Plasmodium-refractory mosquitoes to be 
effective they need to be able to thrive in nature and to compete successfully with 
nontransformed conspecifics. Two lines of transgenic An. gambiae were used in this 
study to evaluate the fitness consequences of transgenesis in this insect.  Life table 
characteristics of two transformed An. gambiae lines were compared to a control line 
to determine if fitness costs were present.  Specific traits measures between transgenic 
and control mosquitoes were not significantly different, and the transgenic lines had 
no evidence of position effects.
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INTRODUCTION
The malaria problem 
Malaria is one of the deadliest diseases worldwide, affecting an estimated 200 to 
300 million victims each year (Budiansky 2002).  Two million of those infected, most 
of them children, die of this disease each year.  Cases are concentrated in tropical and 
sub- tropical regions, which cover over 100 countries (Gallup and Sachs 2001, 
Budiansky 2002).  Malaria has heavy costs not only in human life but also in 
economic losses.  In 1995, countries sustaining high rates of malaria had incomes only 
35% of non- malaria countries (Gallup and Sachs 2001).  This impact is especially 
noticeable in Africa, where up to 90% of all worldwide malaria cases occur (Breman 
2001, Moreira et al. 2002).  
While local residents either die in childhood or attain a level of resistance, non-
natives are left extremely vulnerable to the disease.  Once contracted, malaria is not 
always curable.  Even if the infected individual has medical access, anti-malarial drugs 
may be ineffective because of widespread pathogen resistance. The disease pathogen 
has largely become resistant to chloroquine and pyrimethamine, the most common 
anti- malarial drugs(Cotran et al. 1998).   New medicines have not been developed for 
decades (Cotran et al. 1998, Hemingway et al. 2002).  
In addition, strategies aimed at controlling the mosquito vectors of malaria, have 
been hampered by insecticide resistance.  Previous malaria eradication efforts had 
emphasized eradication of all potential mosquito vectors. Beginning in the 1940s, the 
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insecticide DDT was thought to be an ideal way to eliminate mosquitoes and thus the 
diseases they vector. Worldwide efforts of mosquito control using insecticides were 
initially successful at reducing mortality due to malaria (Sachs 2002).  However, this 
approach was soon hampered by the evolution of insecticide-resistant mosquitoes.  By 
the 1960s, pesticide effectiveness was substantially reduced due to widespread 
mosquito resistance of DDT, malathion and other insecticide eradication tools.  The 
rates of malaria infection rebounded to the levels observed before the use of DDT 
(Hemingway et al. 2002, Sidhu et al. 2002, Wellems 2002). Recently, insecticide-
treated bed nets have been distributed as a means of mosquito control.  They has been 
shown to reduce malaria mortality in children by 15 to 25 percent in heavily infected 
areas (Vogel 2002).  Although insecticide resistance and other issues complicate 
vector-control, pesticides are still considered the most effective method of reducing 
malaria.    
Malaria transmission
Plasmodium are the intracellular protozoan parasites that cause malaria.
Several Plasmodium pathogens, the deadliest of which is P. falciparum, are capable of 
infecting humans.  While P. vivax and P. malariae infections are associated with mild 
anemia, P. falciparum induces severe anemia and renal failure.  The Plasmodium
parasite depends on Anopheles mosquitoes to find human hosts.  Sixty species of 
Anopheles mosquito vectors exist worldwide and mosquito species vary by region. 
Common species include An. stephensi and An. culicifacies in India and An. darlingi
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in South America.  The deadliest Anopholes species, An. gambiae, is found in Africa. 
This species carries several Plasmodium pathogens of humans, including P. 
falciparum.  An. gambiae is responsible for an estimated 1 million malaria deaths each 
year, roughly half the total malaria-caused mortality (Cotran et al. 1998, Budiansky 
2002, Roberts 2002).  
An. gambiae are highly anthropophilic mosquitoes.  As a result of this 
specialization, this species is only found in human- populated areas where females 
exclusively take human blood meals.  An. gambiae females prefer to oviposit in 
shallow, temporary pools such as irrigation ditches, small puddles or even the water 
pooled in human or livestock tracks.   The mosquitoes are active blood feeders at 
night; during the day most can be found taking shelter in human dwellings (Budiansky 
2002). 
Female Anopheline mosquitoes require a blood meal to induce and provision her 
eggs (Cotran et al. 1998, Roberts 2002).  They locate potential human hosts through 
cues such as heat, carbon dioxide, and odors (Hurd 2003).  Anophelines have specially 
formed mouth parts and unique salvitory enzymes to optimize human bloodmeal 
acquisition (Hurd 2003).  Two pairs of cutting stylets line the proboscis, which 
contains modified feeding tubes.  This allows for cross directional cutting of the skin 
surface and smooth insertion of the proboscis.  Once inserted in the skin, one set of 
stylets withdraws blood and the other injects salvia into the wound.  The salvia 
includes anti-inflammatory and anti- clotting enzymes that keep the blood vessel open 
and delay pain response from the host (Budiansky 2002, Enserink 2002).  
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The Plasmodium flaciparum pathogen has a complex human-mosquito-human life 
cycle (Figure 1).  Anopheles females become infected with Plasmodium gametocytes 
picked up from human malaria victims. In order to obtain the Plasmodium pathogen 
and thus begin the infection cycle, a human host must have become infected at least 2 
weeks prior to the Anopheles blood meal.  This time-span is needed for gametocytes, 
the only stage that mosquitoes can aquire from humans, to form in the human host 
(Bannister and Mitchell 2003).    
Multiple infections are common; sexual reproduction of Plasmodium occurs inside 
the mosquito vector (Elliot et al. 2002).  Once ingested, Plasmodium develops in the 
mosquito midgut.  Fertilization of gametocytes to form ookinetes takes place in the 
mosquito mid-gut.  The ookinetes then penetrate the mosquito gut wall, forming 
oocysts in the basement membrane of the gut.  After 10-18 days, the oocysts rupture.  
This releases human- infective sporozoites, which migrate to the salivary glands of the 
mosquito.  The infected mosquito then transmits the pathogen to new human hosts 
during subsequent blood meals.  This transmission process is enhanced by 
Plasmodium- induced behavioral changes in the mosquito. Plasmodium has been 
shown to reduce the vector’s feeding efficiency and thus increase the frequency of 
blood meals required (Hogg and Hurd 1995, Koella et al. 1998, Anderson et al. 2000, 
Hurd 2003).  The vectoring female Anopheles is only malaria infective if takes another 
blood meal at least 10-18 days after it acquires Plasmodium. This time span is needed 
for the Plasmodium parasite to develop into sporozoites, the form that can be passed to 
humans.  Thus, this transmission cycle is highly dependent on mosquito longevity.
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Once sporozoites are injected into the human bloodstream, they infect the host’s 
liver cells and develop into merozoites.  After 8 days, merozoites rupture and infect 
red blood cells. While in red blood cells, they change into trophozoites, develop into 
the ring form, and finally become mature schizonts.  In this form Plasmodium
ruptures, releasing merozoites and causing exponential infection of red blood cells.  
This rupture causes the human’s symptoms: violent chills followed by fever and 
headache.  Over a few weeks, the merozoites become gametocytes and thus available 
for mosquito transmission. If left untreated, anemia, blocked vessels, and even kidney 
failure will result (Cotran et al. 1998, Bannister and Mitchell 2003). 
Mosquito transformation
Genetic alteration of mosquitoes offers a possible solution to the complex malaria 
problem.  Though genetic manipulation as a vector control method has been discussed 
since the 1960s (Curtis 1968), improvements in the last 15-20 years associated with 
genetic technologies have revived the concept (Atkinson et al. 2001).  Genetic 
transformation is the introduction of heritable genetic material from one individual to 
another.  There has been previous success with genetic control programs, such as 
screwworm fly (Cochliomygia hominovorax) eradication through release of sterile 
males (Krafsur et al. 1986).  The concept behind genetically modified mosquitoes 
(henceforth GMM) is the idea that potential vectors can be modified through the 
introduction of novel genes that prevent parasite transmission. 
Three main challenges impede the creation of transgenic mosquitoes (O'Brochta 
2002).  The first challenge is delivering the desired DNA (via fine glass needle) into 
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the germ cells of a mosquito egg without physical damage.  The second challenge is 
that, once inserted, this introduced DNA plasmid must rapidly recombine with the 
mosquito’s chromosomal DNA.  Significant research has been dedicated to 
discovering new gene insertion methods.  In the past two decades, techniques 
involving transposable elements, viruses and in vivo recombination systems have all 
been studied as potential gene vectors (Atkinson et al. 2001). The third challenge is 
integration of the inserted DNA.  A transposable element introduced with the desired 
gene (a.k.a. “transposon”) solves this problem.  
Several transposable elements have been isolated from various insect species and 
successfully used to shuttle genes into mosquitoes including: Hermes, Mariner, Minos
and piggyBac (Atkinson and Michel 2002, Moreira et al. 2002, O'Brochta 2002).  
These transposable elements have the additional advantage of potentially creating a 
genetic drive system.  By their nature, transposable elements may insert themselves 
into non-carrier gametes and thus be over-represented in following generations.  This 
drive system allows the desired transgene, in this case a Plasmodium refractory 
protein, to be expressed above a Mendelian ratio (Kidwell and Ribeiro 1992).
After the transposon- injected egg develops into an adult and mates with no non-
transformed conspecifics, transgenic progeny may be produced.  However, due to the 
inexact nature of transposon insertion, only 10% of the resulting offspring will be fully 
transgenic (O'Brochta 2002). As a result, successfully transformed offspring must be 
easily identified and isolated.  Mutant genes with an associated phenotype, such as the 
white-eye mutation in Aedes aegypti, have used to create and distinguish transgenic 
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germ-lines (Lobo et al. 2002).  However, many mutations bear a fitness cost and thus 
are not widely used.  More commonly, new transgenes with obvious phenotypes, such 
as autoflouresent proteins, are used (O'Brochta 2002).  The enhanced green 
fluorescent protein (EGFP, Figure 2) is the most popular for mosquito transformation 
and has been used in the transformation of several species (Catteruccia et al. 2000, 
Pinkerton et al. 2000, Allen et al. 2001, Grossman et al. 2001, Perera et al. 2002).  The 
fitness cost of these markers are considered to be neutral, though some evidence 
indicates otherwise (Liu et al. 1999).
An. gambiae was the first mosquito species for which genetic transformation was 
reported (Miller et al. 1987).  Miller et al. attempted transformation with the 
Drosophila transposable P-element.  After thousands of attempts, one embryo was 
transformed with a gene that confers resistance to a neomycin analog, G-418.  Despite 
this success, the results indicated that this transformation was not a result of the P-
element transposition.  Clearly, further gene vector development was needed (Moreira 
et al. 2002).
The advent of mosquito gene vector and recombination technology reignited 
genetic modification efforts for An. gambiae.  In addition, the An. gambiae genome 
was published in 2002, which revealed new potential targets for genetically- based 
control (Holt et al. 2002).   Furthermore, the mosquito genes and pathways involved in 
vectoring malaria can be pinpointed; this discovery will elucidate previously unknown 
details about malaria transmission.  In 2000, Grossman et. al reported stable 
transformation of An. gambiae  to express the EGFP marker using the newly-
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developed piggyBac transposable element (Grossman et al. 2001).  Recently, this 
success was extended when Plasmodium refractory genes were inserted into a 
transformed An. gambiae germ-line (Kim et al. 2004) .
In addition, other Anopheline species have been genetically modified in the effort 
to eliminate malaria.  An. stephensi, the major malaria vector on the Indian 
subcontinent, has also been a subject of genetic control research.  This species has 
been transformed with the Minos transposon to express an EGFP marker (Catteruccia 
et al. 2000) and with the piggyBac transposon to express the red fluorescent protein, 
dsRED (Nolan et al. 2002).  An. albimanus is a significant South American malaria 
vector, also present in the southwestern United States.  Germ-line transformation of 
this species was also achieved with a piggyBac transposon containing the exogenous 
EGFP marker (Perera et al. 2002).  
Genetical modification of mosquito vectors from other disease systems has also 
been accomplished.  Aedes aegypti, a vector of yellow fever and dengue virus, has 
been a focus of genetic modification efforts.  In 1998, stable integration of the 
Drosophila melanogaster cinnabar gene with the transposon Mariner (Mos1-cn+) into 
an Aedes aegypti germ-line was one of the first successful mosquito transformation 
experiments (Coates et al. 1998).  Ae. aegypti has also been transformed to express 
markers Drosophila melanogaster cinnabar (cn) (Jansinskiene et al. 1998), luciferase 
(luc) (Coates et al. 1999) and EGFP (Pinkerton et al. 2000) with the Hermes
transposon.  The piggyBac transposable element has also been a gene vector for EGFP 
transformation (Kokoza et al. 2001) and for cn , the Drosophila eye color gene.  
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Finally, Culex quinequesfasciatus,a vector for West Nile Virus, has been transformed 
to express EGFP with the Hermes transposable element (Allen et al. 2001).  
That many species that have been successfully transformed in the past few years 
demonstrates the feasibility of genetic transformation (O'Brochta 2002). The ultimate 
goal in the development of transgenic An. gambiae is their release into a natural 
system.  Instead of attempting to eradicate all malaria mosquitoes, this approach 
proposes to eliminate mosquitoes’ ability to vector the disease.  Ideally, genetically 
modified mosquitoes would displace or out- compete endemic mosquito populations 
in hyper-endemic areas of Africa.  For this strategy to succeed, the released transgenic 
mosquitoes must have fitness equal or greater to their wild counterparts (Scott et al. 
2002).  
Genetic drive is a general term referring to situations of increased transmission 
patterns.  Transposons can be “driven” by virtue of their super-Mendelian enhanced 
transmission rates. The characteristics and potential use of transposable elements and 
transposons has been described and modeled (Kidwell and Ribeiro 1992, Ribeiro and 
Kidwell 1994).  The enhanced transmission of transposons is the consequence of the 
replicative nature of transposition.  Genetic drive describes any alteration of the 
genetic transmission system that may enhance spread of the transgene.  For example, 
if a transgene’s replication is pre-meiotic, the transgene will be over-represented in the 
resulting gametes.  Thus, an increased fraction of the gametes will contain the 
transgenic allele.  This greatly increases the transgenic allele’s rate of spread in the 
population to a rate significantly higher that Mendelian expectations.  Even if there is 
a fitness cost associated with the transgenic allele, its spread through a population may 
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still be rapid because of the “drive” provided by the transposable elemnet.  However, 
it is unknown if this phenomenon will occur in transgenic mosquito species.  Still, 
transposable element genetic drive must be considered, along with fitness, in 
understanding the dynamics of introduced genes in natural populations (Ribeiro and 
Kidwell 1994).
Kim, et al. describe the methods used to genetically transform the An. gambiae
mosquito lines used in this study (Kim et al. 2004).  These mosquitoes have been 
genetically transformed to block the development of P. falciparum, the deadliest 
malaria pathogen. To create the transgenic lines, a piggyBac transposable element that 
contained EGFP and a Plasmodium refractory gene was injected into developing 
mosquito embryos.  The piggyBac gene vector was co-injected with a helper plasmid, 
phsp-pBac.  This makes the gene vector motile and, because this plasmid can be 
activated via heat shock, it adds another level of regulation to the transgenic 
expression.     The refractory gene, An. gambiae cecropin A(AngCecA), is a natural 
part of the An. gambiae immune system.  It has known anti-Plasmodial activity 
(Gwadz et al. 1989, Vizioli et al. 2000).  To gain entrance to the insect hemolymph, 
Plasmodium exploits the An. gambiae midgut, where cecropin is not expressed.  
However, when the AngCecA gene is inserted and regulated with the Aedes aegypti 
carboxypeptidase A (CP) promoter, it exhibits ectopic expression (i.e. occurring in a 
novel position) in the female mosquito’s mid gut after bloodmeals.  This blocks 
Plasmodium passage through the midgut.  Because peptide expression is up- regulated 
in the female mosquito digestive track to aid in digestion post-bloodmeal, the CP A 
promoter linked to AngCecA is only transcribed after bloodmeals.  This time and site 
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specific expression ensures that the extra cecropin is only present when the female 
mosquito is vulnerable to infection.  
Once transcribed, the cecropin is either secreted or released intercellularly.  
Cecropin is then able to destroy Plasmodium via cell membrane disruption (exact 
mechanism is unknown) (Gwadz et al. 1989, Vizioli et al. 2000).  Bioassays 
performed on transformed insects reveal that cecropin transcription in the An. gambiae
midgut causes a 60% decrease in relative Plasmodium infection (Kim et al. 2004).
Two plasmids (piggyBac and a helper plasmid) were injected into embryos of G3/ 
wild-type An. gambiae.  The injected embryo ultimately produces transformed germ-
line cells that, following mating with a nontransformed male, develop into transformed 
F1 individuals.  The EGFP fluorescent gene used as a marker provides a phenotypic 
indication that mosquitoes contain the Plasmodium refectory gene. It is controlled 
through separate regulation and thus is expressed for all transgenics, not just females 
post-bloodmeal. EGFP screens can therefore be used to identify transformed 
mosquitoes as larvae. The transformed founders of the G1 and G2 An. gambiae lines 
underwent several generations of full- sib mating in order to create individuals with 
homozygous genotypes at the cecropin gene and EGFP marker.  This entire process 
was performed twice, once to form the transformed G1 line and again to produce the 
transformed G2 line  (Kim et al. 2004).
Fitness costs
Fitness costs associated with transgenic alleles may have several causes.  
Transposable elements used in creation of transgenic lines are known to cause 
12
mutations and may disrupt normal gene function.  Because two independently 
transformed lines (G1 and G2) are being compared to the control line (G3), position 
effects are possible.  This effect is the difference between transgenic lines due to 
insertion site of the transgene.  Detecting potential position effects between G1 and G2 
is another goal of my study.  Fitness costs may be associated with the gene expression; 
excess production of cecropin may lead to an energy or resource trade-off that lowers 
fitness.  Also, the location of transgene insertion may cause an interruption of 
important pre-existing genes in the chromosome.  This disruption would also 
ostensibly lead to reduced transgene fitness.  Also, high levels of EGFP expression 
have been shown to induce cell apoptosis, indicating a toxic effect that may have 
fitness consequences (Liu et al. 1999). Furthermore, transformed mosquitoes must be 
isolated and full-sib mating must occur to establish a transgenic germ-line (Yan et al. 
1997, Catteruccia et al. 2003).  This requires at least two generations of inbreeding, 
which accelerates allele fixation and may, via inbreeding depression, reduce offspring 
growth and increase offspring mortality via inbreeding depression (Armbruster et al. 
2000).  
Past work with transgenic Drosophila suggests that genetic manipulation has 
an impact on fitness (Woodruff 1992).  Recent work examining transgenic mosquitoes 
supports the claim that creating a transgenic insects have a considerable fitness costs 
(Tiedje et al. 1989, Yan et al. 1997, Irvin et al. 2002, Catteruccia et al. 2003) (but see: 
(Moreira et al. 2003).  
A recent study by Catteruccia et al. found reduced fitness of transgenic An. 
stephensi (Catteruccia et al. 2003).   Competitive ability of transgenic An. stephensi
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was measured by establishing a free-breeding population with equally represented 
transgenic and non- transgenic mosquitoes.   In the presence of competition, the 
frequency of the transformed allele was lower than expected (based on Hardy-
Weinberg Equilibrium) and decreased for 4-16 generations, when all transgenic lines 
became extinct.  Thus, wild- type An. stephensi mosquitoes were found to be superior 
competitors to transgenic mosquitoes.  This suggests that transgenic alleles contain 
some sort of selective disadvantage in a competitive situation.  
With the exceptions of An. gambiae (Kim et al. 2004) and Ae. Aegypti (Coates et 
al. 1999, Kokoza et al. 2001, Lobo et al. 2002), few mosquito species have been 
successfully transformed to include a marker and a Plasmodium refractory gene.  In 
few cases have the fitness consequences of transformation been evaluated.  A life table 
analysis has been performed on Ae. aegypti transformed to express EGFP with Hermes
and Mos1 transposable elements.  The study revealed fitness deficits in transgenic 
lines of this insect compared to wild, non-transformed types (Irvin et al. 2002).  No 
published studies address the fitness consequences of transformation of An. gambiae, 
the major African malaria vector responsible for half of all malaria deaths. 
The goal of this experiment is to determine the fitness costs associated with two 
genetic transformation events in An. gambiae.  This study is a detailed life-table 
analysis designed to identify the life stages causing fitness differences in transformed
An. gambiae.  The variables measured included larval and adult duration, adult 
survivorship, fecundity and estimated intrinsic rate of increase for two strains of 
genetically modified An. gambiae and the non-transformed strain. Because previous 
studies indicated that transgenesis reduces fitness, it was predicted that non-
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transformed mosquitoes would have a higher mean fitness.  It was expected that 
significantly higher survivorship, fecundity and/or growth rate would indicate this 
higher relative fitness.  In addition, life table statistics were compared between the two 
transformed lines to see if different strains bear significantly different fitness costs, 




A lab strain of  An. gambiae named G3 was genetically transformed using the 
piggyBac transposable element, following techniques described by Kim et al. (Kim et 
al. 2004).The vector, pPBMG-CEC , contained EGFP and An. gambiae cecropin 
A(AngCecA), a Plasmodium refractory gene located downstream of the promoter 
Aedes aegypti carboxypeptidase A (CP). Eggs were collected from An. gambiae
females 72-120 hours after blood meal.  The eggs were desiccated and covered with 
Halocarbon oil.  The gene vector pPBMG-CEC was co-injected with the piggyBac
helper element phsp-pBac into An. gambiae embryos. After injection, the oil was 
removed and larvae were reared using standard techniques (Kim et al. 2004).  Founder 
adults that developed from the transformed eggs were backcrossed to wild type G3 
adults.  The offspring from these matings were screened for expression of the 
transgene via EGFP.  Those individuals expressing the EGFP were sib-mated to create 
homozygous transgenic lines.    Two independent transformations were preformed to 
produce two separately transformed lines, designated G1 and G2.  These lines contain 
the same transgenes but they likely differ in the location of the transgenes integration 
in the mosquito genome.
Experimental design
 To compare the lifetime fitness of transformed and non-transformed lines, the 
life table characteristics of the three An. gambiae lines, the non-transformed G3, and 
the transformed lines, G1 and G2, were examined in controled environmental 
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conditions.   One day after emergence, two hundred first instar larvae from each line 
were placed into two larval pans (100 larvae each) (Figure 3).  Each tray contained 20 
identical cups holding 5 larvae each in equal volumes of distilled water (Figure 4).  
The number of live larvae in each cup was recorded daily.    Once they began to 
appear, the numbers of pupae per cup were also recorded daily. All of the pupae from 
the same line were collected daily and placed in a new cup of distilled water within a 
separate adult cage.  Each cage was then labeled with the mosquito line, number of 
individuals, and date of pupation (Figure 5).  Each cage was checked to see when 
pupae eclosed.  After all individuals successfully emerged as adults or died, the pupal 
cup was removed.  The adults were fed ad libitum with cotton soaked in 10% sugar 
solution.  The cotton was replaced every other day until all adults had died. Larvae and 
adults were held in 26.5 C temperature and 85% humidity growth chambers with a 16 
hour light 8 hour dark photocycle. This experiment was replicated three times, 
beginning on July 14th, August 7th and September 9th, 2003 (referred in analysis as 
“Replicates”).
Fecundity of An. gambiae females was measured for the individuals in adult 
cages that contained a minimum of 5 females and 5 males as potential mates.  Blood 
meals are required for female egg production. Because An. gambiae females are 
anthropophilic, human blood meals were offered.  Cages 4-6 days old with the 
required number of individuals were given a human blood meal.  In order to perform 
this, cages were placed in darkness to simulate night feeding conditions. The human 
host’s arm (always the same host) was held up to the mesh top of the adult cage, 
allowing the females to feed freely.  Each cage was exposed to the blood meal for 10-
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15 minutes, until all females had completed feeding.  The sex ratio was also known, so 
the number of females available for oviposition was recorded each day. 
One day following the blood meal a cup with a moistened filter paper substrate 
for oviposition was added to these cages.  The filter paper was removed (covered with 
eggs) and replaced daily until no eggs were produce for two consecutive days.  Each 
filter paper was preserved in a labeled plastic bag and stored at -20°C.  The number of 
eggs per female per day was counted for each line.  Fecundity measures were taken 
during replicates 1 and 3, when a human host was available to administer blood meals.
Egg hatch rate of the stock populations of G1, G2 and G3 mosquitoes was also 
measured.  Adult cages from each line with over 150 bloodfed females were sampled.   
Two replicates of this experiment were performed.  For replicate 1, adult females 7 
days post pupal emergence were used.  For replicate 2, adult females were 4 days post 
emergence. The younger females were thought to have enhanced fecundity compared 
to the replicate 17 day old females because fecundity decreases as adult females age 
(Gilles and Wilkes 1965). Samples were taken from the filter paper used for 
oviposition for each available cage.  From the papers containing over 1,000 eggs, three 
subsets of 50 eggs from each line were sampled.  The eggs were chosen on the day of 
oviposition.  The groups of 50 eggs per line were placed on separate pieces of 
moistened filter paper and allowed two days to hatch.  After two days, the numbers of 
newly hatched larva from each batch were counted.  
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Analysis
I tested for effects of several variables related to fitness.  Variables examined 
included r values, larval and adult duration, adult survivorship, fecundity and egg 
hatch rate.   The intrinsic rate of growth of a population, defined as r ~ = ln(R0)/T, is 
an overall fitness indicator.   It combines information from both survivorship and 
fecundity, termed net reproductive rate per generation (R0), as well as age at 
reproduction (T).  This value was used because it is the most comprehensive life table 
parameter and therefore the most comprehensive with which to compare populations.
ANOVA was used to test for effects of experimental replicate and mosquito 
line on intrinsic rate of growth (r).   Replicates 1 and 3 only were used to calculate 
mean r value because bloodmeals were given during these replicates.  Consequently, 
fecundity could only be determined for these replicates.   Fecundity was measured as 
(total number of eggs produced / number of females) per cage each day.  
The initial 200 larvae for each mosquito line were subdivided into 40 groups of 5 
to test for larval cup duration (Figure 3, 4).  ANOVA was used to test for effects of 
larval cup duration and mean duration.  Larval cup duration was determined by the 
number of days a cup was occupied by at least one individual larva.   Mean larval 
duration was measured as the mean number of days larvae survived per line. 
To determine adult cage duration and longevity, newly ecolosed adults were 
caught daily by line.  Because the availability of adults varied each day, cages 
contained a range of individuals; some held only one adult while others contained over 
50.  To evaluate the effects of adult density on longevity, ANOVA was performed 
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based on data from individuals from line G1 (replicate 1).  The effects of initial 
density on longevity were tested.
Adult cage duration was defined as the number of days at least one individual was 
present per cage and longevity was measured as the mean number of days that adults 
survived.   Each replicate was individually analyzed via ANOVA to determine if there 
was an effect of line during any given replicate.  
Survivorship curves were formed to represent the survivorship of adults from 
each line.   All survivorship graphs display replicate 1 and 3 data, the replicate where 
selected adult females received bloodmeals.  The graphs were standardized so that 
lines start at 100 percent.  Survivorship is shown beginning the day after bloodmeals 
were administered.  The first survivorship curve (Figure 6) displays the survivorship 
of all adults in replicates 1 and 3.   The second survivorship curve (Figure 7) is the 
most specific because it isolates the female mosquitoes from all lines that have 
received a bloodmeal.  Mean survivorship for all bloodfed females was also analyzed 
with ANOVA.
Egg hatch rate (mean number of eggs hatched form each subset of 50) was 
analyzed by two-factor ANOVA without replication.  This tested the mean hatch
rate for each line during two independent replicates. 
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RESULTS
Intrinsic rate of increase (r)
The intrinsic rate of increase (r) was similar for all lines during experimental 
replicates 1 and 3 (Table 1a).   The control line, G3, had an r value of 0.151 (SE
±0.28), which is intermediate to G1 (0.145 ±0.31) and G2 (0.164 ±0.43), the 
transgenic lines.   The variance of G3 was 2.7^-4, larger than the variance of the 
transgenic lines G1 (2.80^-5) and G2 (1.18^-4).  Neither line (p= 0.08) nor replicate 
(p= 0.15) was a significantly less varied within groups (Table 1b).  Even within each 
replicate, line was not a significant factor (p= 0.10 for replicate 1, p=0.93 for replicate 
3) (Table 1c). 
Larval duration
Mean larval cup duration was similar for all lines during replicates 1, 2 and 3 
(Table 2a).  Lines averaged about 12 days (SE range ± 0.2-0.28) of larval duration for 
replicate 1.  Variance was highest for transgenic line G2 at 40.80 days; variance was 
just 1.74 for G1 and 3.05 for G3.  Although the non-transgenic line went through the 
larval stage about 0.5 day faster than either transgenic lines, that difference was not 
significant (p= 0.48) (Table2b). 
Because of improved mosquito rearing techniques from the final two 
replicates, there was increased uniformity within lines for the second and third 
replicate.  Variances was small during replicates 2 and 3, all lines were at or below 
1.3.  The mean larval cup duration decreased by almost half for replicates two and 
three (Table 2a).  Though this created a highly significant effect of replicate (p<0.001) 
21
(Table 2b), duration remained similar across all lines.  More importantly, ANOVA 
indicated no interaction between replicate and line (p= 0.70) (Table 2b).  The 
difference in replicate did not disrupt the trends found between and within lines on any 
replicate.   
G1 averaged 6.38 ± 0.094 and 6.65 ± 0.161 days in larval cup duration for 
replicates 2 and 3; G2 averaged 6.15 ±0.0865 and 7.18 ± 0.183 days.  The non-
transgenic line (G3) averaged 6.03 ± 0.026 days, below the transgenic lines, for 
replicate 2.  For the final replicate, G3 averaged 6.85 ± 0.086 days, above both 
transgenic lines.  There were no significant differences between larval cup duration, 
though G3 did avergae about a half day shorter than either transgenic.  All lines had a 
reduced larval duration and variance for replicates 2 and 3 (Table 2a).
Mean duration displayed similar trends (Table 3a).  The mean number of days 
that individuals spend in the larval stage was the shortest, 6.46 ±0.14 days, for 
replicate 1.  The variance, 0.05, was also the highest in replicate 1.  Mean duration 
during replicate 3 was 5.58 ± 0.07 days, close to replicate 1, but with a variance of 
only 0.01.  Duration dropped to an mean of 3.37 ± 0.04 days during replicate 2 with a 
variance of only 0.004, contributing to the significance of replicate (p<0.001) (Table 
3b).  
All lines had very similar mean duration within and between lines; the 
mosquito line was never found to be a significant factor (p=0.88) (Table 3b).  The 
transgenic line G1 had the longest larval duration of 5.18 ±0.96 days; G1 averaged 
5.11 ±0.86 days (Table 3a). The control line, G3, averaged 5.13 ±0.95 days, slightly 
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closer to line G2.  The variance for G1 and G3 was 2.75 and 2.71, respectively, 
slightly longer than the G2 variance of 2.23.    
Adult duration, longevity and survivorship curves
Analysis of the effects of density on longevity in line G1 did not reveal a 
significant density effect (Table 4a, b).  Adult cage duration did not differ significantly 
among replicates (p=0.075) (Table 5b).  For replicates 1 and 3 adults cages were 
occupied a mean of 36.05 ±2.11 and 36.50 ±1.26 days.  Mean cage duration for 
replicate 2 was 43.01 ±1.54 days, several days longer than the other replicates (Table 
5a).   When characterized by line, adult cage duration is also comparable; lines are 
within about three days of each other.  The transgenic lines G1 and G2 averaged 36.66 
± 2.32 and 39.21 ± 2.12 days while the control line G3 averaged 39.21 ± 3.32 days 
(Table 5a).  ANOVA revealed that there is no effect of line on adult cage duration 
(p=0.469) (Table 5b).  Even when replicates are isolated and lines are analyzed via 
single factor ANOVA, there are still no significant differences in cage duration.  The 
effects of line were p = 0.28, p = 0.42 and p = 0.29 for replicates 1,2 and 3 (Table 5c).
Mean adult longevity was similar between lines for each replicate (Table 6a).  
During replicate 1, adults lived a mean of 16.29 ± 0.78 days, with a variance of 1.82.  
Longevity increased to a mean of 17.75 ± 0.37 for replicate 2, but variance decreased 
to 0.42.  Longevity and variance were both lowest for replicate 3; adults lived a mean 
of 15.07 ±0.16 days with a variance of 0.08.  This decrease in variance between 
replicates 1 and 2-3 is due to a learning curve; longevity was more uniform with each 
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successive replicate.  This caused replicate to be a significant factor in the ANOVA 
(p=0.04) (Table 6b). 
 Lines did not have significantly different adult longevity (p = 0.33) (Table 6a).  
All lines had means within about one day of each other.  Transgenic line G2 had the 
shortest mean longevity of 15.73 ±0.67 days with the smallest variance, 1.34.  
Transgenic line G1 and control line G3 had similar mean longevities, 16.54 ±1.02 with 
variance of 3.12 and 16.84 ±0.88 with variance of 2.31, respectively.   Line was not a 
significant factor (p=0.33) (Table 6b).
Mean longevity for females post- bloodmeal was similar across lines and 
replicates (Table 7a).  Mean longevity decreased from 11.51 ±0.23 days during 
replicate 1 to 11.48 ±0.57 days during replicate 3, a difference of only 0.03, while 
variance increased from 0.17 to 0.96.  These differences between replicate were not 
significant (p=0.98) (Table 7b).  The mean longevity between lines of bloodfed 
females differed by less than one day.   The transgenic line, G2, averaged 11.34 ±0.29 
days with a variance of 0.28 (Table 7a).  The control line, G3, averaged 11.13 ±0.70 
days, similar to G2, but with a higher variance of 0.97.   Transgenic line G1 had the 
highest adult longevity post bloodmeal, a mean of 12.01 ±0.37 days with a variance of 
0.28.  Lines were not significantly different (p=0.63) (Table 7b).
Adult survivorship curves also show the relative survivorship of adults from 
each line for replicates 1 and 3 (Figures 6,7).  Survivors are plotted as a fraction of the 
founding population.  The overlapping survivorship curves reinforce the idea that only 
slight, random variations existed between the lines (Figure 6).    Survivorship curves 
show the highest divergence when displaying transgenic lines expressing both EGFP 
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and ectopic cecropin verses the control line (Figure 7). In fact, this plot of bloodfed 
females over time shows transgenic lines with a 3 or 4 day increase in survivorship as 
compared to the control line G3 (replicate 3).  This agrees with the mean longevity of 
bloodfed females (Table 7), which also shows slightly higher survival for transgenic 
lines.  
Egg hatch rate
The mean egg hatch rate did not differ among lines (p=0.53) (Table 8b).  The 
control line averaged 26.7 ±0.33 eggs hatched out of 50, slightly smaller than 28 ±0.67 
eggs for G2 and virtually the same as 26 ±0.33 eggs for G1 (Table 8a).  Females 4 
days post-emergence (used in replicate 2) had an mean of 27.1 ±0.78, which was not a 
significantly higher hatch rate when compared to 26.7 ±0.51 for 7 day females (used 
in replicate 1).  About 27 eggs out of each subset of 50 hatched regardless of if the 





The object of this research was to determine if Anopheles gambiae mosquitoes 
transformed with the piggyBac transposable element to express EGFP and ectopic 
cecropin experience a reduction in fitness.  It was predicted that all life table 
characteristics would be reduced for transgenic lines as compared to a non-transgenic 
control line.   However, larval development time, adult longevity, fecundity, 
survivorship and egg hatch rate did not differ significantly between transgenic and 
control lines for any given experimental replicate.  
The intrinsic rate of increase, an overall fitness measure, was not significantly 
different between transgenic and control lines.  In fact, the quantitatively highest r 
value was 0.164 ±0.43 for G2, a transgenic line. The cecropin transgene and EGFP in 
lines G1 and G2 were both engineered to be fully expressed in adult females post-
bloodmeal; this was expected to reduce intrinsic growth rates for transgenic 
populations. Instead, all mosquito lines had quantitatively similar rates of intrinsic 
growth.  
In addition, there were no significant differences between  any larval or adult 
growth variables.  Interestingly, adult longevity was longer during the second 
experimental replicate, when no mosquitoes received bloodmeals.   Mean adult 
longevity was about 4 days longer, and adult cages were occupied an about 7 days 
longer in replicate 2 (for replicates p = 0.04, p = 0.075).  The acquisition of human 
bloodmeals and/ or egg production by females may involve an obligate energy and 
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fitness tradeoff.  Studies of reproductive tradeoff indicate that  longevity tends to 
increase when reproductive efforts are minimized (Schluter et al. 1991). During 
replicate 2, females may have increased in fitness because they were not allowed to 
expend energy towards reproductive efforts.  Investigating energy tradeoff between 
reproduction and fitness was not a goal of my study, though this is an important topic 
in malaria transmission research. 
Survivorship curves also show trends of adult survivorship.  The first 
survivorship curve shows mean survivorship across all individuals in each line (Figure 
6).  Replicates 1 and 3 were selected because mosquitoes were administered 
bloodmeals during these runs.  For transgenic mosquitoes, females that received 
bloodmeals were the only individuals engineered to express both EGFP and ectopic 
cecropin.  When survivorship of all individuals is displayed, the lines are nearly 
indistinguishable.  Instead of G3 showing enhanced survivorship, it slowly declined 
over time at approximately the same rate as the two transgenic lines.   
 A higher level of differentiation is seen when examining only the transgenic 
mosquitoes expressing cecropin and EGFP verse the control line (Figure 7).  The 
standardized graph of bloodfed females survivorship displays a much more 
pronounced divergence between all lines in replicates 1 and 3.  In fact, replicate 3 
survivorship curves indicate enhanced survival of transgenic lines G1 and G2 relative 
to non-transgenic G3.  The mean adult survivorship of bloodfed females is also 
slightly longer for transgenic lines G1 (12.01 ±0.37 days) and G2 (11.34 ±0.29 days) 
than for the control line (11.13 ±0.70 days). This improved survivorship of transgenic 
lines when expressing both a refractory and marker is also contradictory to the fitness 
27
costs predicted.  This increased survivorship of transgenics is a non- significant (mean 
longevity p= 0.63) but highly relevant trend.  
Egg hatch rate was also an exclusive product of bloodfed females and thus 
expected to be influenced by both the EGFP marker and the ectopic cecropin 
transgene.  Thus, the hatch rate may be considered an estimate of adult fitness as well 
as a larval trait.  However, there were no differences in egg hatch rate between 
transgenic and control mosquitoes.  Therefore, throughout all aspects of the adult life 
stage, there was no detectable fitness load of transgenics to compromise the fecundity 
or survivorship.  Adult survivorship and fecundity data only provides further evidence 
to refute the prediction that transgenes bear fitness costs.
Expression of transgene may influence costs
Several aspects of the transgene are potential sources of fitness costs. The use 
of the effector gene, cecropin, as well as the EGFP marker gene may have inherent 
costs due to expression or position effects associated with the insertion site.  Though 
cecropin is a natural aspect of mosquito immunity, increased expression of this 
defensive compound may involve energy or fitness trade-offs (Cotter et al. 2004).  To 
compensate for this, ectopic cecropin is regulated for expression at a specific time and 
tissue.  In addition, the protein itself is part of innate mosquito immunity, which may 
help reduce fitness costs associated with the transformed mosquito lines.  Transgenic 
adult females that received bloodmeals expressed Plasmodium refractory cecropin in 
their mid gut; these individuals were expected to bear the highest fitness costs due to 
expression of additional transgenes.  However, no significant fitness differences were 
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found that suggest costs associated with cecropin transgene expression.  Thus, ectopic 
cecropin does not appear to be costly to produce.
The EGFP marker gene is an excellent way to identify and screen transgenic 
mosquitoes, but it may also be a source of fitness costs.  While the time and location 
of the cecropin gene was highly regulated, the EGFP marker had more generalized 
expression throughout all life stages.  The fluorescence is expressed in the neural 
tissue and anal papillae of larva and limited to expression in the optic lobes of the 
brain for adults (O'Brochta 2004).  Some work has suggested that EGFP marker 
expression induces apoptosis (programmed cell death) and thus bears insidious fitness 
costs (Liu et al. 1999).  In addition, a life table study of Aedes aegypti and a 
competition study of An. stephensi found that mosquitoes transformed to express 
EGFP were less fit than their non transgenic counterparts (Irvin et al. 2002, 
Catteruccia et al. 2003). While the EGFP marker may be somewhat costly to produce, 
it does not appear to have any negative fitness impacts in this study.  
Two transgenes (EGFP and cecropin) with separate regulation were used to 
create these transgenic lines.  Because G1 and G2 were independently transformed 
germ-lines, it is likely that the transgenes were inserted into different locations of the 
An. gambiae genome.    The location of insertion may disrupt other gene expression, 
causing different position effects in each line.  Despite this possibility, there were 
never significant differences in fitness traits between the two transgenic lines.  Thus, 
there is no evidence that position effects are present between these two transgenic 
lines.  
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A recent life-table study of transgenic An. stephensi also found minimal fitness 
costs associated with transgenic lines (Moreira et al. 2003).  Moreira et al. concluded 
that fitness costs were due to the product of the transgene, not its site of insertion.    A 
population cage experiment testing competition as well as a life table study compared 
mosquito lines transformed with different effector genes (SMI and PLA2) to a non-
transformed control line.    SMI lines (transformed with the SMI peptide tetramer) 
showed no reduced fitness or indications of position effects between lines (Moreira et 
al. 2003).  This SMI transgene, similar to the ectopic cecropin produced in the 
transgenic An. gambiae of our study (AngCecA), is time and tissue specific.   
Additional, unobserved components of fitness may be affected by transgenesis. 
Resistance to pathogens and extreme conditions, such as heat, should also be 
considered before a full conclusion can be drawn.  In addition, a competition study 
that tracks the frequency of the AngCecA transgene over several generations may 
reveal subtle differences between G1, G2 and G3 not measured here.     This type of 
competition study was able to detect differences in fitness between transgenic and 
wild type An. stephensi (Catteruccia et al. 2003).  Though the ectopic cecropin 
transgene does not appear to have any fitness costs, it may affect transgenic mosquito 
behavior, such as competitive mating ability.  In fact, assortative mating is considered 
to be a major hurdle that must be overcome before transgenic mosquitoes are released 
(Reisen 2002, Scott and Morrison 2002).  Future work should compare the mating 
success of transgenic and control mosquitoes as well as determine the frequency of 
matings between transgenic and control lines.  
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Factors that may outweigh fitness costs
Because this study was conducted under the benign conditions of a laboratory, 
its field application is limited.  For instance, this study showed relatively slight 
mortality in stages prior to adult emergence (about 50-75% for all lines) whereas field 
studies indicate that 91.5% of An. gambiae mortality occurs during this period 
(Aniedu et al. 1993).  One significant ecological factor is field exposure to the malaria 
pathogen, Plasmodium falciparum.   This can actually benefit transgenic mosquitoes; 
the fitness costs associated with carrying this pathogen may counteract any 
competitive advantage that non-transgenic mosquitoes have.  While it is possible that 
the non-significant fitness differences found in the laboratory may be magnified in a 
field situation, there may also be an additional advantage for transgenics in the field.  
Costs of carrying Plasmodium
Our experiment focused on the fitness costs of transgenic mosquitoes.  None of the 
lab strains were infected with the Plasmodium falciparum parasite.  However, non-
transformed mosquitoes would be exposed to this pathogen in a field situation.  These 
vulnerable mosquitoes must bear the substantial cost of carrying the Plasmodium
pathogen.  This may counteract whatever costs are associated with genetic 
transformation and thus create a higher relative fitness for transgenic mosquitoes. 
The burden of vectoring Plasmodium has been found to impact the fitness of 
Anopheline mosquitoes in several studies.  Infected An. stephensi were found to have 
reduced fecundity for three gonotrophic cycles, even when oocyst levels were low 
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(Hogg and Hurd 1995).  P.  falciparum sporozoite level has also been linked to 
decreased survival of blood- feeding An. gambiae females (Anderson et al. 2000).  
The presence of this parasite is correlated with reduced blood-feeding efficiency; 
fewer anti-clotting enzymes are produced by infected mosquitoes (Hurd 2003).  
Host manipulation
Parasites manipulate infected females in order to maximize dispersal.   
Apyrase enzyme, used by females to induce blood flow from human hosts, is an 
essential part of acquiring blood meals.  However, this enzyme is present in a much 
lower concentration when the mosquito is infected with Plasmodium.   Reduction in 
the enzyme makes bloodmeals more difficult to obtain from hosts; this increases the 
number of probing attempts, which corresponds with an increase in mortality. Infected 
An. gambiae are more likely to take several bloodmeals from multiple hosts, which is 
risky for the mosquito but beneficial for Plasmodium dispersion (Koella et al. 1998).  
Thus, the malaria parasite manipulates its mosquito host to infect humans more often.  
This fitness reduction in infected wild mosquitoes will increase the relative fitness of 
transgenic mosquitoes that cannot carry pathogen
 However, some work has suggested that An. gambiae survivorship is not reduced 
due to parasite infection, perhaps because the mosquito has evolved to minimize these 
costs (Robert et al. 1990).   Despite this, Plasmodium infection is still generally 
thought to reduce the fitness of  An. gambiae and other vectors (Schwartz and Koella 
2001, Ferguson and Read 2002).  In addition, even a small fitness load inflicted by the 
parasite may translate into a large transgenic advantage in the field.  
32
Ecological models
Modeling simulations give an indication of the relative importance of fitness in 
the dispersion of transgenic mosquitoes (for review: Gould 2004). A model by 
Kiszewski and Spielman incorporated spatial and seasonal discontinuity to determine 
the spread of released transgenic mosquitoes (Kiszewski and Spielman 1998). Their 
model emphasized fitness as the most important factor of transgene dispersal.  In an 
ideal scenario of a 0% fitness reduction of released transgenic mosquitoes relative to 
the wild population, fixation of the transgene may still require up to 200 generations.  
A minimum fitness requirement for a model without environmental structure allows 
for a 50% reduction in fitness of transgenic mosquitoes.  However, once spatial and 
temporal structure (such as village distribution and seasonality) is incorporated, the 
minimum fitness reduction for GMM is limited to 30%.  However, fixation with a 
30% fitness reduction of transgenic may require over 2,000 generations, depending on 
length of breeding season and wet or dry conditions. Only models assuming a 20% or 
smaller reduction in fitness consistently predicted replacement of wild mosquitoes 
with released transgenic mosquitoes.   Fixation of the transgene in the wild population 
would occur only after 150 generations. It was predicted that high release ratios and 
annually repeated releases only aid in dispersion if fitness was above a minimum 
threshold of 70% relative to wild (no more than 30% reduction).  When transposon 
drive (i.e. “genetic drive”) was taken into account for simulations, the minimum 
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relative fitness was only reduced to 70% (30% reduction) and 140 generations were 
needed to achieve fixation.
However, other models predicted more optimistic outcomes once the genetic 
drive of the transposon was taken into account.  Ribeiro and Kidwell created a simple 
population model that varied fitness costs and integration transmission rates of the 
transgene.  The results indicated that transgenic mosquitoes could spread through wild 
population even with 50% fitness costs.   
A simulation model by Boete and Koella also predicts the outcome of a GMM 
release aided by transpose drive (Boete and Koella 2002).  In addition to a transposon 
drive mechanism, this model assumed a single refractory gene and a reduction in 
fitness due to transgenesis.  Two alternates of the model determined the spread of the 
refractoriness; one assumed fixed (constant) costs while the other assumed conditional 
(dependent upon Plasmodium infection) costs of the transgene.  In both versions, the 
transposon may drive refractory genes into the population, even if there are substantial 
fitness costs as long as the benefits of refractoriness outweigh the costs.    In fact, in 
the presence of a drive system, there is even the potential to drive the refractory gene 
to fixation in the wild population.  There is a caveat; effective refractoriness will 
reduce the number of infected mosquitoes, but fewer infected mosquitoes means less 
selection pressure for refractoriness.  Thus, epidemiological feedback would lessen 
selection pressure for refractoriness that is not close to100%. As a result, this model 
predicts that the introduced gene must be nearly 100% refractory in order to have a 
large impact on malaria.  
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Transgenic Mosquitoes: Challenges and Promises
Lowered fitness of transgenic mosquitoes is only one of many concerns about 
the potential release of these organisms into the wild.  A myriad of other ecological 
concerns have been raised regarding the topic.  A 2002 conference at Wageningen, 
The Netherlands was held exclusively on the topic of ecological challenges to 
releasing transgenic mosquitoes.  The proceedings of this conference outline several 
major problems with the assumption that transgenic mosquitoes will be able to 
eradicate disease (2002). Yet there is still an overall deficiency of work in ecology, 
population genetics and simulation models to compliment the exhaustive genetic work 
devoted to creating transgenic mosquitoes. 
The problem of a reliable genetic drive mechanism, which is integral to a 
successful transgenic program, is a concern often raised in the literature e.g.(Alphey et 
al. 2002, Scott et al. 2002, Boete and Koella 2003).  Genetic drive is needed to ensure 
a high frequency of the Plasmodium refractory transgene in the wild mosquito 
population (see “Introduction: Mosquito transformation” for discussion of drive 
system theory).  Mosquito germ-lines can now be reliably transformed using 
transposable elements that have inherent genetic drive.   Genes linked to transposable 
elements are capable of being represented in a disproportionately large number of 
gametes (Kidwell and Ribeiro 1992, Ribeiro and Kidwell 1994).   Ideally, this drive 
mechanism will compensate for small fitness reductions associated with the transgene.  
Though transposable elements solve the problem of finding a drive mechanism, there 
is still a possibility that the elements will dissociate from transgenes engineered to 
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refract Plasmodium.  This would circumvent its intended purpose of spreading the 
novel gene through a wild mosquito population.
Another argument against the release of transgenics stems from the shortcomings 
of sterile male release programs in the 1970s and 80s.  The sterilization and release of 
Anopheles, Culex and Aedes disease vector mosquitoes proved to be a failure, mainly 
due to the dearth of ecological considerations, such as mating and oviposition 
preference (Lounibos 2002, Reisen 2002).  However, these difficulties may be avoided 
if field ecology is incorporated into GMM research and employed in any attempted 
release strategy. Further research on understudied areas of mosquito ecology, such as 
male biology and mating behavior, would help elucidate the conditions needed to 
encourage wild-transgenic mosquito matings and thus aid the spread of a transgene 
through a wild population.  Sterile male release programs found that little to no cross 
breeding occurred between wild mosquito populations and the sterile males released 
(Reisen 2002).  Thus, assortative mating is likely to be a substantial obstacle that must 
be overcome to ensure dispersal of a Plasmodium refractory transgene.  
Colonization efforts may be thwarted by lab selection, which favors different 
phenotypes than the natural mosquito environment.  For example, the lab-adapted 
mosquitoes is the Aedes aegypti sterile male release failed to colonize village 
dwellings or oviposit in clay pots like wild mosquitoes (Lounibos 2002).  Enclosed 
greenhouse experiments that reproduce the environmental conditions a mosquito in the 
wild would encounter (i.e. Semi-Field tests) may be the next step to determine if lab 
adaptation will be a problem for transgenic mosquitoes.  Raising transgenics in this 
type of setting may also be the best way to reintroduce selection for field- related 
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fitness traits.  Semi-field tests have already been successfully used to investigate the 
behavioral ecology of non-transgenic mosquito vector species (Knoles and Scott 
2002).  These tests could be used to expand current laboratory work and determine 
relative fitness of transgenic and wild mosquitoes in a realistic environment.
Semi-field experiments as well as observational studies of wild mosquitoes are 
needed to gain insight about optimal release conditions.  Any potential release must be 
carefully predetermined to give genetically modified mosquitoes the best possible 
chance of mating success with their wild counterparts.   Precise ecological 
recommendations must be followed in order to maximize mating success.  Time, 
location, and photoperiod, for example, must be appropriate to optimize cross matings 
between wild and genetically modified mosquitoes (Reisen 2002).
There are large wild populations of mosquito vectors such as An. gambiae, yet 
only about 2%-6% of these mosquitoes are infective (Gilles and Wilkes 1965).  As a 
result, there must be a very large number of transgenic mosquitoes released in order to 
effectively reduce this small fraction of infected wild vectors.   As a result, release 
ratios suggested based on previous experiments are as high as 10 transgenic 
mosquitoes for every wild mosquito (Spielman 2002).  However, this estimate 
assumes no genetic drive and fitness costs to transgenesis, release ratios may be 
substantially lower without these limitations.
Population subdivision is a key factor in the success of any vector control 
strategy.  Even if an introduced transgene is 100% refractory and bears no fitness 
costs, simulation models show that its spread is highly dependent on metapopulation 
structure (Taylor and Manoukis 2002).  Review studies suggest that An. gambiae has a 
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high level of genetic diversity and one major subdivision that separates north-western 
and a south-eastern African populations (Lanzaro and Tripet 2002).   In addition to An. 
gambiae sensu stricto, The An. gambiae complex incorporates 6 species with varying 
degrees of genomic differences.  The overall population structure consists of co-
occurring species and various intermediate chromosomal forms.  In West Africa, gene 
flow was found to be high within chromosomal forms and moderate between forms.  
Gene flow was limited between species (Taylor et al. 2001). If this is true for most 
endemic areas, the inconsistency of gene flow will be a challenge that should be 
considered in transgenic mosquito programs.  For instance, genetically distinct groups 
may require separate releases in order to ensure sufficient spread of the transgene.  
Despite this complication, the subdivision present in An. gambiae  populations may 
present an advantage: it would reduce the introduction threshold (number of 
mosquitoes released to transform a population) (Lanzaro and Tripet 2002). Population-
specific introductions of transformed An. gambiae may overcome the release ratio 
problem and enhance spread of the transgene.
Once in the natural environment, transgenic mosquitoes may alter the human-
mosquito-human transmission cycle.  Environmental cues may modify the physiology 
of gene expression of cause selection for or against a transgene (Billingsley 2002).  
Evolutionary responses may also alter parasite virulence, vector longevity and human 
infection rate.  For instance, the introduction of transgenic mosquitoes would likely 
lower the degree of multiple Plasmodium infections in humans (Elliot et al. 2002).  
This would decrease Plasmodium transmission, which may result in reduced pathogen 
virulence.  Ideally virulence to the human host would be diminished; however, the 
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burden of carrying Plasmodium may be reduced for mosquito vectors (Elliot et al. 
2002).  If the later occurs, there would no longer be a relative fitness benefit for 
mosquitoes to parasite-free.  This may ultimately reduce the spread of transgenic 
mosquitoes (Boete and Koella 2002).   
  The risk of contracting malaria can be quantified using the entomological 
inoculation rate (EIR), the number of “infective” mosquitoes (with sporozoites) biting 
a person per unit time (Charlwood et al. 1998).  Research shows that if transmission is 
lowered, there is the potential for a rebound effect (Smith et al. 2001).  Normally 
children contract infections that give them a degree of immunity as an adult; primary 
malaria infection as an adult is more likely to be fatal.  Lower EIR creates unstable 
malaria, or a reduction in “human herd immunity.”  The result is a rebound in the 
number of cases once the non-immune children become infected as adults.  However, 
studies of bed-nets treated with insecticides have thus far shown no evidence of 
rebound effects, suggesting that refractory transgenes would not be likely to 
exacerbate malaria morbidity (Curtis 2002). In addition, if genetically modified 
mosquitoes are limited to one type of malaria vector such as An. gambiae, children 
may acquire fewer infections and eventual resistance from other, less fatal vectors 
(Scott et al. 2002).  Though there is some concern about malaria spreading via non 
GMM vectors, no Anopheline vectors are as anthropophilic and thus as deadly as An. 
gambiae.  
Finally, the ethical, legal and social concerns inherently linked to a potential 
release must be fully addressed (Touré et al. 2002).  The public must be involved in 
the process in order to be convinced that this method of malaria control is a safe and 
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effective one.  Thus far, there has been a high public investment in the development of 
genetically modified mosquitoes.   Unfortunately this has been, to some extend, at the 
expense of ecological and behavioral research.  It is now imperative that the ecological 
as well as social considerations now take center stage in the GMM quest for malaria 
control.
There is enough evidence to support cautious optimism about the potential of 
release of genetically modified An. gambiae.  Finding fitness to be similar for wild and 
transgenic mosquitoes is an encouraging step, not an indication that GMM are ready 
for release.  Hopefully concern over the ecological aspects of introducing transgenics 
will incite ecologist and geneticists to work together to do work in behavioral ecology, 
population genetics and enclosed field trials. Though the ecological concerns brought 
up in the Wageningen conference are undoubtedly valid, the concept of genetic 
modification should not be abandoned.  While genetic modification alone may not be 
sufficient to eradicate malaria, it may have a powerful impact when combined with 





G1 0.145 ±0.31 2.80E-5 
G2 0.164 ±0.43 1.18E-4 
G3 0.151 ±0.28 2.74E-4 
(b)
Source of 
Variation df MS P-value
Replicate 1 3.6E-4 0.08
Line 2 1.8E-4 0.15




Variation df MS P-value
Between Groups 2 9.4E-05 0.10
Within Groups 6 0.005
Replicate 3
Source of 
Variation df MS P-value
Between Groups 2 0.0003 0.93
Within Groups 9 0.0047
TABLE 1: 
(a) Intrinsic rate of growth comparison.  The intrinsic rate of growth for three lines 
of An. Gambiae, two transformed (G1, G2) and one untransformed control (G3) for 
replicates 1, 2 and 3.
(b) P- values.  ANOVA of effects of lines and replicate and error on the intrinsic rate 
of growth.  Only replicates 1 and 3 were analyzed because bloodmeals were given 
during these replicates. (Bloodmeals are required for fecundity to be measured)  
(c) P-values by replicate.  ANOVA of effects of line on intrinsic rate of 
































Source of Variation df MS P-value
Replicate 2 1.44E 3 < 0.001
Line 2 4.04 0.48
Interaction 4 3.03 0.70
Within 351 5.43
TABLE 2:
(a) Larval cup duration comparison.  Larval cup duration of three lines of An. 
Gambiae, two transformed (G1, G2) and one untransformed control (G3) for replicates 
1, 2 and 3.




Number of Days Variance
Replicate 1 6.46 ±0.14 0.05
Replicate 2 3.37 ±0.04 0.004
Replicate 3 5.58 ±0.07 0.01
G1 5.18 ±0.96 2.75
G2 5.11 ±0.86 2.23
G3 5.13 ±0.95 2.71
(b)
Source of Variation df MS P-value
Replicate 2 7.63 <0.001
Line 2 0.00 0.88
Error 4 0.03
TABLE 3:  
(a) Mean larval duration.  The mean larval duration of three lines of An. 
Gambiae, two transformed (G1, G2) and one untransformed control (G3) for 
replicates 1, 2 and 3.
(b) P-values.  ANOVA of effect of replicate and line on larval duration. The mean
of each line per replicate was treated as a unit, thus, error degrees of freedom are 4.  
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(a)
Cage Survivorship Initial 
density
Variance
111 25.64 ±7.32 11 107.11
112 27.28 ±3.41 34 23.28
113 27.44 ±20.27 68 822.51
114 26.08 ±6.54 13 85.50
115 10.80 ±2.10 15 8.82
(b)
Source of 
Variation df MS P-value
Cage 4 382.52 0.34
Survivorship 1 56.97 0.66
Error 4 247.56
TABLE 4:
(a) Adult cage density comparison.  Adult cage density comparison transformed An. 
gambiae line G1 for replicate 1.  This is representative of other lines and replicates. 




G1 G2 G3 Mean
Variance
*R 1 32.28 ±3.64 36.28 ±3.15 39.57 ±2.61 36.05 ±2.11 13.32
  R 2  40.20 ±2.52 43.33 ±2.40 45.50 ±0.50 43.01 ±1.54 7.10
*R 3 37.50 ±2.50 38.00 ±1 34.00 ±0 36.50 ±1.26 4.75
mean 36.66 ±2.32 39.20 ±2.12 39.69 ±3.32
Variance 16.19 13.50 33.07 
(b)
Source of 
Variation df MS P-value
Replicate 2 45.54 0.075














Lines 2 93.19 0.28
Between 







Variation df MS P-value
Between Groups 2 9.50 0.29
Within Groups 3 4.83
TABLE 5:
(a) Adult cage duration comparison.  Adult cage duration of three lines of An. 
Gambiae, two transformed (G1, G2) and one untransformed control (G3) for replicates 
1, 2 and 3.
(* indicates full transgene expression by bloodfed females.)
(b) P-values.  ANOVA of effect of replicate and line on adult cage duration. 
(c) P- values by replicate.  ANOVA of effect of line on adult cage duration during 
individual replicates.  
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(a)
Number of Days Variance
Replicate 1 16.29 ±0.78 1.82
Replicate 2 17.75 ±0.37 0.42
Replicate 3 15.07 ±0.16 0.08
G1 16.54 ±1.02 3.12
G2 15.73 ±0.67 1.34
G3 16.84 ±0.88 2.31
(b)
Source of 
Variation df MS P-value
Replicate 2 5.43 0.04
Line 2 0.98 0.33
Error 4 0.67
TABLE 6:
(a) Mean adult longevity.  Mean adult longevity of three lines of An. Gambiae, two 
transformed (G1, G2) and one untransformed control (G3) for replicates 1, 2 and 3.
(b) P-values.  ANOVA of effects of replicate and line on adult longevity.  The mean 
of each line per replicate was treated as a unit, thus, error degrees of freedom are 4.  
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(a)
Number of Days Variance
Replicate 1 11.51 ±0.23 0.17
Replicate 3 11.48 ±0.57 0.96
G1 12.01 ±0.37 0.28
G2 11.34 ±0.29 0.17
G3 11.13 ±0.70 0.97
(b)
Source of 
Variation df MS P-value
Replicate 1 7E -4 0.98
Line 2 0.42 0.63
Error 2 0.71
TABLE 7: 
(a) Mean longevity for bloodfed females.  Mean longevity for bloodfed females of 
three lines of An. Gambiae, two transformed (G1, G2) and one untransformed control 
(G3) for replicates 1 and 3. (No bloodmeal occurred during replicate 2)
(b) P-values.  ANOVA of effects of replicate and line on mean longevity of bloodfed 
females.  The average of each line per replicate was treated as a unit, thus, error 




Replicate 1 0.533 26.7 ±0.51 0.778
Replicate 2 0.542 27.1 ±0.78 1.81
G1 0.52 26 ±0.33 0.222
G2 0.56 28 ±0.67 0.889
G3 0.533 26.7 ±0.33 0.222
(b)
Source of 
Variation df MS P-value
Replicate 2 2.33 0.96
Line 6 51.89
TABLE 8: 
(a) Egg hatch rates.  Egg hatch rate for three lines of An. Gambiae, two transformed 
(G1, G2) and one untransformed control (G3) for 2 replicates. The mean number of 
successfully hatched eggs is out of subsets of 50.
(b) P- values.   ANOVA of effects of replicate and line on egg hatch rate.
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FIGURE 1: The Plasmodium life cycle. This complicated malaria disease cycle 
involves obligate human and mosquito stages.
http://www.dpd.cdc.gov/dpdx/HTML/Image_Library.htm
CDC Parasite Image Library
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FIGURES
FIGURE 2: Transgenic mosquito larvae. This An. stephensi individual is expressing 
enhanced green fluorescent protein (EGFP), the same marker gene used for the An. 
gambiae in this study.
http://library.wur.nl/frontis/malaria/index.html
Proceedings of the Frontis workshop on ecological challenges concerning the use of 
genetically modified mosquitoes for disease control
Wageningen, The Netherlands 26-29 June 2002
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 Replicate 1                Replicate 2   Replicate 3
   July 14th August 7th                   September 9th
FIGURE 3: Larval tray set-up. The entire setup was repeated for three replicates.  
Five first-instar larvae were placed in each cup. There were two trays for each 
mosquito line.  There were 20 cups/100 larvae in each tray, summing to 40 cups/200 
larvae per line.  Survivorship was recorded daily by determining the number of larvae 
in each cup.  Pupae were counted, removed, and placed in an adult cage.   
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FIGURE 4: Larval Cup.  Each cup was numbered and labeled with the appropriate 
line.  Five first- instar larvae were placed in each cup one day after hatch.  Larvae 
were fed every other day until all individuals had died or pupated.
FIGURE 5:  Adult cage.  Adult cages were labeled with the number of pupae, date, 
and mosquito line.  Adult survivorship was determined by counting number of 
individuals each day. Adults were fed every other day with a sugar pa soaked in 10% 
sugar solution.  Certain adult cages with sufficient females were chosen for blood 
meals.  The human hosts arm was placed over the mesh top of the cage to allow for 
feeding.  The quantity of eggs standardized by the number females in the cage each 
day was recorded and used to estimate fecundity.
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FIGURE 6: Adult survivorship curve; Percent alive vs. day (Replicates 1 and 3).   
Survivorship curves display mean survivorship of all individuals from of three lines of 
An. Gambiae, two transformed (G1, G2) and one untransformed control (G3) for 
replicates 1 and 3.  (No bloodmeal occurred during replicate 2)
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FIGURE 7: Adult survivorship curve; Bloodfed females (Replicates 1 and 3).
Survivorship curves display mean survivorship of bloodfed females from three lines of 
An. Gambiae, two transformed (G1, G2) and one untransformed control (G3) for 
replicates 1 and 3.  (No bloodmeal occurred during replicate 2)
54
REFERENCES
2002. Ecological aspects for application of genetically modified mosquitoes. In W. 
Takken and T. W. Scott [eds.]. Kluwer Academic Publishers, Dordrecht.
Allen, M. L., D. A. O_Brochta, P. W. Atkinson, and C. S. Levesque. 2001. Stable, 
germ-line transformation of Culex quinquefasciatus (Diptera: Culicidae). 
Journal of Medical Entomology 38: 701-10.
Alphey, L., C. B. Beard, P. Billingsley, M. Coetzee, A. Crisanti, C. Curtis, P. 
Eggleston, C. Godfray, J. Hemingway, M. Jacobs_Lorena, A. A. James, F. 
C. Kafatos, L. G. Mukwaya, M. Paton, J. R. Powell, W. Schneider, T. W. 
Scott, B. Sina, R. Sinden, S. Sinkins, A. Spielman, Y. Toure, and F. H. 
Collins. 2002. Malaria control with genetically manipulated insect vectors. 
Science 298: 119-21.
Anderson, R. A., B. G. Knols, and J. C. Koella. 2000. Plasmodium falciparum 
sporozoites increase feeding-associated mortality of their mosquito hosts 
Anopheles gambiae s.l. Parasitology 120 ( Pt 4): 329-33.
Aniedu, I., M. J. Mutinga, and C. M. Mutero. 1993. Vertical estimates of 
survivorship of larvae and pupae of Anopheles gambiae Giles complex in 
Baringo District, Kenya. Insect Science and its Application 14: 39-48.
Armbruster, P., R. A. Hutchinson, and T. Linvell. 2000. Equivalent inbreeding 
depression under laboratory and field conditions in a tree-hole-breeding 
mosquito. Proceedings of the Royal Society of London Series B- Biological 
Sciences 267: 1939-1945.
Atkinson, P. W., and K. Michel. 2002. What's buzzing? Mosquito genomics and 
transgenic mosquitoes. Genesis 32: 42-48.
Atkinson, P. W., A. C. Pinkerton, and D. A. O'Brochta. 2001. Genetic 
transformation systems in insects. Annual Review of Entomology 46: 317-346.
Bannister, L., and G. Mitchell. 2003. The ins, outs and roundabouts of malaria. 
Trends in Parasitology 19: 209-13.
Billingsley, P. F. 2002. Environmental constraints on the physiology of transgenic 
mosquitoes, pp. 149-161. In W. Takken and T. W. Scott [eds.], Ecological 
aspects for application of genetically modified mosquitoes. Kluwer Academic 
Publishers, Dordrecht.
Boete, C., and J. C. Koella. 2002. A theoretical approach to predicting the success of 
genetic manipulation of malaria mosquitoes in malaria control. Malaria Journal 
1.
Boete, C., and J. C. Koella. 2003. Evolutionary ideas about genetically manipulated 
mosquitoes and malaria control. Trends in Parasitology 19: 32-8.
Breman, J. G. 2001. The ears of the hippopotamous: manifestatitions, determinations, 
and estimates of the malaria burden. American Journal of Tropical Medicine 
and Hygiene 64: 1-11.
Budiansky, S. 2002. Creatures of our own making. Science 298: 80-6.
Catteruccia, F., C. J. Godfray, and A. Crisanti. 2003. Impact of genetic 
manipulation on the fitness of Anopheles stephensi mosquitoes. Science 299: 
1225-1227.
55
Catteruccia, F., T. Nolan, T. G. Loukeris, C. Blass, F. Savakis, F. C. Kafatos, and 
A. Crisanti. 2000. Stable germline transformation of the malaria mosquito, 
Anopheles stephensi. Nature 405: 959-962.
Charlwood, J. D., T. Smith, A. Lyimo, A. Y. Kitua, H. Masanja, M. Booth, P. L. 
Alonso, and M. Tanner. 1998. Incidence of Plasmodium falciparum infection 
in infants in relation to exposure to sporozoite-infected Anophelines. American
Journal of Tropical Medicine and Hygiene 59: 243-251.
Coates, C. J., N. Jansinskiene, L. Miyashiro, and A. A. James. 1998. Mariner 
transposition and transformation of the yellow fever mosquito, Aedes aegypti. 
Proceedings of the National Academy of Sciences 95: 3748-3751.
Coates, C. J., N. Jasinskiene, G. B. Pott, and A. A. James. 1999. Promoter-directed 
expression of recombinant fire-fly luciferase in the salivary glands of Hermes-
transformed Aedes aegypti. Gene 226: 317-25.
Cotran, R. S., T. Collins, and V. Kumar. 1998. Robbins Pathological Basis of 
Disease. Elsevier Science.
Cotter, S. C., L. E. B. Kruuk, and K. Wilson. 2004. Costs of resistance: genetic 
correlations and potential trade-offs in an insect immune system. Journal of 
Evolutionary Biology 17: 421-429.
Curtis, C. F. 1968. Possible use of translocations to fix desirsble genes in insect pests. 
Nature 218: 368-369.
Curtis, C. F. 2002. Measuring public-health outcomes of release of transgenic 
mosquitoes., pp. 223-234. In W. Takken and T. W. Scott [eds.], Ecological 
aspects for application of genetically modified mosquitoes. Kluwer Academic 
Publishers, Dordrecht.
Elliot, S. L., M. W. Sabelis, and F. R. Adler. 2002. Evolution of parasite virulence to 
vectors, pp. 163-171. In W. Takken and T. W. Scott [eds.], Ecological aspects 
for application of genetically modified mosquitoes. Kluwer Academic 
Publishers, Dordrecht.
Enserink, M. 2002. What mosquitoes want: secrets of host attraction. Science 298: 
90-2.
Ferguson, H. M., and A. F. Read. 2002. Why is the effect of malaria parasites on 
mosquito survival still unresolved? Trends in Parasitology 18: 256-261.
Gallup, J. L., and J. D. Sachs. 2001. The economic burden of malaria. The American 
Journal of Tropical Medicine and Hygiene 64: 85-96.
Gilles, M. T., and T. J. Wilkes. 1965. A Study of the age-composition of poulations 
of Anopheles gambiae Giles and A. funestus giles in north-eastern Tanzania. 
Bulletin of Entomological Research 56: 237-262.
Grossman, G. L., C. S. Rafferty, J. R. Clayton, T. K. Stevens, O. Mukabayire, 
and M. Q. Benedict. 2001. Germline transformation of the malaria vector, 
Anopheles gambiae, with the piggyBac transposable element. Insect Molecular 
Biology 10: 597-604.
Gwadz, R. W., D. Kaslow, J.-Y. Lee, W. L. Maloy, M. Zasloff, and L. H. Miller. 
1989. Effects of magainins and cecropins on the sporogonic development of 
malaria parasites in mosquitoes. Infection and Immunity 57: 2628-2633.
Hemingway, J., L. Field, and J. Vontas. 2002. An overview of insecticide 
resistance. Science 298: 96-7.
56
Hogg, J. C., and H. Hurd. 1995. Plasmodium yoelii nigeriensis: the effect of high 
and low intensity of infection upon the egg production and bloodmeal size of 
Anopheles stephensi during three gonotrophic cycles. Parasitology 111 ( Pt 5): 
555-62.
Holt, R. A., G. M. Subramanian, A. Halpern, G. G. Sutton, R. Charlab, D. R. 
Nusskern, P. Wincker, A. G. Clark, J. M. Ribeiro, R. Wides, S. L. 
Salzberg, B. Loftus, M. Yandell, W. H. Majoros, D. B. Rusch, Z. Lai, C. L. 
Kraft, J. F. Abril, V. Anthouard, P. Arensburger, P. W. Atkinson, H. 
Baden, V. de_Berardinis, D. Baldwin, V. Benes, J. Biedler, C. Blass, R. 
Bolanos, D. Boscus, M. Barnstead, S. Cai, A. Center, K. Chaturverdi, G. 
K. Christophides, M. A. Chrystal, M. Clamp, A. Cravchik, V. Curwen, A. 
Dana, A. Delcher, I. Dew, C. A. Evans, M. Flanigan, A. 
Grundschober_Freimoser, L. Friedli, Z. Gu, P. Guan, R. Guigo, M. E. 
Hillenmeyer, S. L. Hladun, J. R. Hogan, Y. S. Hong, J. Hoover, O. Jaillon, 
Z. Ke, C. Kodira, E. Kokoza, A. Koutsos, I. Letunic, A. Levitsky, Y. 
Liang, J. J. Lin, N. F. Lobo, J. R. Lopez, J. A. Malek, T. C. McIntosh, S. 
Meister, J. Miller, C. Mobarry, E. Mongin, S. D. Murphy, D. A. 
O_Brochta, C. Pfannkoch, R. Qi, M. A. Regier, K. Remington, H. Shao, 
M. V. Sharakhova, C. D. Sitter, J. Shetty, T. J. Smith, R. Strong, J. Sun, 
D. Thomasova, L. Q. Ton, P. Topalis, Z. Tu, M. F. Unger, B. Walenz, A. 
Wang, J. Wang, M. Wang, X. Wang, K. J. Woodford, J. R. Wortman, M. 
Wu, A. Yao, E. M. Zdobnov, H. Zhang, Q. Zhao, et al. 2002. The genome 
sequence of the malaria mosquito Anopheles gambiae. Science 298: 129-49.
Hurd, H. 2003. Manipulation of medically important insect vectors by their parasites. 
Annual Review of Entomology 48: 141-161.
Irvin, N., M. S. Hoddle, D. A. O'Brochta, and B. Carey. 2002. Assessing fitness 
costs for transgenic Aedes aegypti expressing the green fluorescent protien 
marker and transposase genes. Proceedings of the National Academy of 
Sciences 101: 891.
Jansinskiene, N., C. J. Coates, M. Q. Benedict, C. S. R. Cornel, A. A. James, and 
F. H. Collins. 1998. Stable transformation of the yellow fever mosquito, Aedes 
aegypti, with the Hermes elemnet from the housefky. Proceedings of the 
National Academy of Sciences 95: 3743-3747.
Kidwell, M. G., and J. M. C. Ribeiro. 1992. Can transposable elements be used to 
drive disease refractoriness genes into vector populations? Parasitology Today 
8: 325-329.
Kim, W., H. Koo, A. M. Richman, D. C. J. Seeley, J. Viziolo, A. D. Klocko, and D. 
A. O'Brochta. 2004. Ectopic expression of a cecropin transgene in the human 
malaria vector Anopheles gambiae (Diptera: Culicidae): Effects on 
susceptibility to Plasmodium. Journal of Medical Entomology 41: 447-455.
Kiszewski, A. E., and A. Spielman. 1998. Spatially explicit model of transposon-
based genetic drive mechanisms for displacing fluctuating populations of 
anopheline vector mosquitoes. Journal of Medical Entomology 35: 584-590.
Knoles, B. G. J., and T. W. Scott. 2002. Discussion - Ecological challenges 
concerning the use of genetically-modified mosquitoes for disease control: 
synthesis and future perspectives, pp. 235-242. In W. Takken and T. W. Scott 
57
[eds.], Ecological aspects for application of genetically modified mosquitoes. 
Kluwer Academic Publishers, Dordrecht.
Koella, J. C. 2002. On the evolutionary ecology of mosquito immunity and the use of 
transgenic mosquitoes for malaria control, pp. 173-185. In W. Takken and T. 
W. Scott [eds.], Ecological aspects for application of genetically modified 
mosquitoes. Kluwer Academic Publishers, Dordrecht.
Koella, J. C., L. S. Flemming, and R. A. Anderson. 1998. The malaria parasite, 
Plasmodium falciparum, increases the frequency of multiple feeding of its 
mosquito vector, Anopheles gambiae. Proceedings of the Royal Society of 
London Series B- Biological Sciences 265: 763-768.
Kokoza, V., A. Ahmed, E. A. Wimmer, and A. S. Raikhel. 2001. Efficient 
transformation of the yellow fever mosquito Aedes aegypti using the piggyBac 
transposable element vector pBac[3xP3-EGFP afm]. Insect Biochemistry and 
Molecular Biology 31: 1137-43.
Krafsur, E. S., H. Townson, G. Davidson, and C. F. Curtis. 1986. Screwworm 
eradication is what it seems. Nature 323: 495-496.
Lanzaro, G. C., and F. Tripet. 2002. Gene flow among populations of Anopheles 
gambiae: a critical review, pp. 109-132. In W. Takken and T. W. Scott [eds.], 
Ecological aspects for application of genetically modified mosquitoes. Kluwer 
Academic Publishers, Dordrecht.
Liu, H. S., M. S. Jan, C. K. Chou, P. H. Chen, and N. J. Ke. 1999. Is green 
fluorescent protein toxic to the living cells? Biochemical and Biophysical 
Research Communications 260: 712-7.
Lobo, N. F., A. Hua-Van, X. Li, B. M. Nolen, and M. J. Fraser. 2002. Germ line 
transformation of the yellow fever mosquito, Aedes aegypti, mediated by 
transpositional insertion of a piggyBac vector. Insect Molecular Biology 11: 
133-9.
Lounibos, L. P. 2002. Genetic-control trials and the ecology of Aedes aegypti at the 
Kenya coast, pp. 33-43. In W. Takken and T. W. Scott [eds.], Ecological 
aspects for application of genetically modified mosquitoes. Kluwer Academic 
Publishers, Dordrecht.
Miller, J. H., R. K. Sakai, P. Romans, R. W. Gwadz, P. Kantoff, and H. G. Coon. 
1987. Stable integration and expression of a bacterial gene in the mosquito 
Anopheles gambiae. Science 237: 776-781.
Moreira, L. A., A. K. Ghosh, A. E. G., and M. Jacobs-Lorena. 2002. Genetic 
transformation of mosquitoes: a quest for malaria control. International Journal 
for Parasitology 32: 1599-1605.
Moreira, L. A., J. Wang, F. H. Collins, and M. Jacobs-Lorena. 2003. Fitness of 
anopheline mosquitoes expressing transgenes that inhibit Plasmodium 
development. Genetics 166: 1337-1341.
Nolan, T., T. M. Bower, A. E. Brown, A. Crisanti, and F. Catteruccia. 2002.
piggyBac-mediated Germline Transformation of the Malaria Mosquito 
Anopheles stephensi Using the Red Fluorescent Protein dsRED as a Selectable 
Marker. Journal of Biological Chemistry 277: 8759-8762.
58
O'Brochta, D. A. 2002. Transgenic mosquitoes: the state of the art, pp. 15-24. In W. 
Takken and T. W. Scott [eds.], Ecological aspects for application of genetically 
modified mosquitoes. Kluwer Academic Publishers, Dordrecht.
O'Brochta, D. A. 2004. Description of drive mechanisms, the ectopic cecropin and 
EGFP transgenes. In D. T. Ladner [ed.], College Park, Maryland.
Perera, O. P., R. A. Harrell, and A. M. Handler. 2002. Germ-line transformation of 
the South American malaria vector, Anopheles albimanus, with a 
piggyBac/EGFP transposon vector is routine and highly efficient. Insect 
Molecular Biology 11: 291-7.
Pinkerton, A. C., K. Michel, D. A. O'Brochta, and P. W. Atkinson. 2000. Green 
flouresent protien as a marker in transgenic Aedes aegypti. Insect Molecular 
Biology 9: 1-10.
Reisen, W. K. 2002. Lessons from the past: an overview of studies by the University 
of Maryland and the University of California, Berkeley, pp. 25-32. In W. 
Takken and T. W. Scott [eds.], Ecological aspects for application of genetically 
modified mosquitoes. Kluwer Academic Publishers, Dordrecht.
Ribeiro, J., and M. G. Kidwell. 1994. Transpoable elements as population drive 
mechanisms: specification of critical parameter values. Journal of Medical 
Entomology 31: 10-16.
Robert, V., J. P. Verhave, and P. Carnevale. 1990. Plasmodium falciparum 
infection does not increase the precocious mortality rate of Anopheles 
gambiae. Transactions of the Royal Society of Tropical Medicine and Hygiene 
84: 346-7.
Roberts, L. 2002. Mosquitoes and disease. Science 298: 82-3.
Sachs, J. D. 2002. A new global effort to control malaria. Science 298: 122-4.
Schluter, D., T. D. Price, and L. Rowe. 1991. Conflicting selection pressures and life 
history trade-offs. Proceedings of the Royal Society of London Series B-
Biological Sciences 246: 11-17.
Schwartz, A., and J. C. Koella. 2001. Trade-offs, conflicts of interest and 
manipulation in Plasmodium- mosquito interactions. Trends in Parasitology 
17: 189-194.
Scott, T. W., and A. C. Morrison. 2002. Aedes aegypti density and the risk of 
dengue-virus transmission, pp. 187-206. In W. Takken and T. W. Scott [eds.], 
Ecological aspects for application of genetically modified mosquitoes. Kluwer 
Academic Publishers, Dordrecht.
Scott, T. W., W. Takken, B. G. Knols, and C. Boete. 2002. The ecology of 
genetically modified mosquitoes. Science 298: 117-9.
Sidhu, A. B., D. Verdier_Pinard, and D. A. Fidock. 2002. Chloroquine resistance in 
Plasmodium falciparum malaria parasites conferred by pfcrt mutations. 
Science 298: 210-3.
Smith, T. A., L. Regula, and C. Lengeler. 2001. Child mortality and malaria 
transmission intensity in Africa. Trends in Parasitology 17: 145-149.
Spielman, A. 2002. Release ratios employed for genetically modifying populations of 
mosquitoes, pp. 209-215. In W. Takken and T. W. Scott [eds.], Ecological 
aspects for application of genetically modified mosquitoes. Kluwer Academic 
Publishers, Dordrecht.
59
Taylor, C. E., and N. C. Manoukis. 2002. Effective population size in relation to 
genetic modification of Anopheles gambiae sensu stricto, pp. 133-146. In W. 
Takken and T. W. Scott [eds.], Ecological aspects for application of genetically 
modified mosquitoes. Kluwer Academic Publishers, Dordrecht.
Taylor, C. E., Y. T. Touré, J. Carnahan, G. Dolo, S. F. Traoré, F. E. Edillo, and 
G. C. Lanzaro. 2001. Gene flow amoung populations of the malaria vector, 
Anopheles gambiae, in Mali, West Africa. Genetics 157: 743-750.
Tiedje, J. M., R. K. Colwell, Y. L. Grossman, R. E. Hodson, R. E. Lenski, R. N. 
Mack, and P. J. Regal. 1989. The planned introduction of genetically 
engineered organisms: ecological considerations and recomendations. Ecology 
70: 298-315.
Touré, Y. T., A. M. J. Oduola, J. Sommerfeld, and C. M. Morel. 2002. Biosafety 
and risk assessment in the use of genetically modified mosquitoes for disease 
control, pp. 217-222. In W. Takken and T. W. Scott [eds.], Ecological aspects 
for application of genetically modified mosquitoes. Kluwer Academic 
Publishers, Dordrecht.
Vizioli, J., P. Bulet, M. Charlet, C. Lowenberger, C. Blass, H. M. Muller, G. 
Dimopoulos, J. Hoffman, F. C. Kafatos, and A. M. Richman. 2000. Cloning 
and analysis of a cecropin gene from the malaria vector mosquito, Anopheles 
gambiae. Insect Molecular Biology 9: 75-84.
Vogel, G. 2002. An elegant but imperfect tool. Science 298: 94-5.
Wellems, T. E. 2002. Plasmodium chloroquine resistance and the search for a 
replacement antimalarial drug. Science 298: 124-6.
Woodruff, R. C. 1992. Transposable DNA elements and life history traits. I. 
Transposition of P DNA elements in somatic cells reduces the lifespan of 
Drosophila melanogaster. Genetica 86: 143-54.
Yan, G., D. W. Severson, and B. M. Christensen. 1997. Costs and benifits of 
mosquito refractoriness to malaria parasites: implications for genetic variablity 
of mosquitoes and genetic control of malaria. Evolution 51: 441-450.
